Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
7900%
Followers on X. Updated Oct 16, 2026
Loading...

Zevra Therapeutics X Follower Count

Zevra Therapeutics has 790 followers on X (formerly Twitter), roughly flat (+1.3%) over the past three months.

With 790 followers, Zevra Therapeutics has a smaller X following than industry peers like Amgen (118,594) and Gilead Sciences (72,240).

How Zevra Therapeutics’s X Growth Feeds the ZVRA AI Score

X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Zevra Therapeutics’s X following into the ZVRA AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.

For Zevra Therapeutics’s reach on other platforms, see Zevra Therapeutics Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.

For real-time conversation volume, see ZVRA X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.

Month over Month X Followers

Sep 2026 789
Aug 2026 786
Jul 2026 782
Jun 2026 782
May 2026 779
Apr 2026 774
Get ZVRA alerts in real-time
The moment the x followers trend turns, sentiment flips, or insiders trade.
Try Stock Alerts Free

Zevra Therapeutics X (Twitter) Followers: Frequently Asked Questions

Zevra Therapeutics has 790 followers (790) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.

Zevra Therapeutics's X following has been roughly flat (+1.3%) over the past three months. View the trend chart above for the full history.

X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Zevra Therapeutics's following can reflect shifting public interest. That is why AltIndex combines Zevra Therapeutics's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.

Zevra Therapeutics underperforms its industry peers when it comes to X Followers, ranking dead last.

With fewer than 1,000 followers, Zevra Therapeutics' X account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.

Sign up and get more insights on Zevra Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.